Putting Viral Clearance Capabilities to the Test: Process understanding and careful assessment of risks are essential in developing viral clearance programs.
| Publicado en: | BioPharm International Vol. 31; no. 5; pp. 18 - 21 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
May2018
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Descripción no disponible. |